General Information
Revision date
2021-11-25
Product name
Acetazolamide Assay Standard
Substance name
C4H6N4O3S2
CAS No.
59-66-5
supplier name
British Pharmacopoeia Commission
Emergency telephone
§45 - (EC)1272/2008
Icons in SDS
Company Information
company name
MHRA
e-mail address of the competent person responsible for the Safety Data Sheet
bpcrs@mhra.gov.uk
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H315, H319, H335, H336, H362
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
2.1 Classification of the substance or mixture
Regulation (EC) No 1272/2008 Skin corrosion/irritation Category 2 - (H315) Serious eye damage/eye irritation Category 2 - (H319) Effects on or via lactation Yes - (H362) Specific target organ toxicity — single exposure Category 3 - (H335, H336)
Contains
Acetazolamide
Signal word
Warning
Hazard statements
H315 - Causes skin irritation H319 - Causes serious eye irritation H335 - May cause respiratory irritation H336 - May cause drowsiness or dizziness H362 - May cause harm to breast-fed children
Precautionary statements
P201 - Obtain special instructions before use P260 - Do not breathe dust/fume/gas/mist/vapours/spray P263 - Avoid contact during pregnancy and while nursing P264 - Wash face, hands and any exposed skin thoroughly after handling P280 - Wear protective gloves and eye/face protection
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information Chemical name EU - REACH (1907/2006) - Article 59(1) EU - REACH (1907/2006) - Endocrine - Candidate List of Substances of Very Disruptor Assessment List of High Concern (SVHC) for Authorisation Substances Acetazolamide -
